Although several studies have demonstrated that the aggressive types of breast cancer, including HER2-positive breast cancer and TNBC, show higher pCR rates and tumor responses to NAC, the extent of microcalcifications did not correlate with tumor responses. Here, ERBB2 is linked to breast cancer.